New medicinal products reimbursed from the Rare Diseases Fund (11954) AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Here is the key information for the supplier regarding the procurement ‘New medicinal products reimbursed from the Rare Diseases Fund (11954)’:

# Procurement object

  • What is being purchased: Medicinal products reimbursed from the Rare Diseases Fund. The procurement is divided into 11 parts (e.g., Belzutifan, Fampridine, Fenfluramine, Levocarnitine, Sotatercept, Maralixibat, Midostaurin, Pegunigalsidase alfa).
  • Technical requirements: Drugs must be registered in the Medicinal Products Register of the Republic of Lithuania or the Community,…
     
    To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

c4t_9438521_1.xml

PD/BPS.docx

PD/BPS priedai.docx

PD/espd-request.pdf

PD/espd-request.xml

PD/Pasiūlymo forma.docx

PD/SPS.docx

PD/Sutarties projektas.docx

PD/Techninė specifikacija ir įkainiai.xlsx

PD.zip

Ready to get started?

Subscribe and enjoy all the benefits every day!